» Articles » PMID: 37142226

Sphingosine-1-phosphate and Its Receptors in Vascular Endothelial and Lymphatic Barrier Function

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2023 May 4
PMID 37142226
Authors
Affiliations
Soon will be listed here.
Abstract

The vascular and lymphatic systems both comprise a series of structurally distinct vessels lined with an inner layer of endothelial cells that function to provide a semipermeable barrier to blood and lymph. Regulation of the endothelial barrier is critical for maintaining vascular and lymphatic barrier homeostasis. One of the regulators of endothelial barrier function and integrity is sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite secreted into the blood by erythrocytes, platelets, and endothelial cells and into the lymph by lymph endothelial cells. Binding of S1P to its G protein-coupled receptors, known as S1PR1-5, regulates its pleiotropic functions. This review outlines the structural and functional differences between vascular and lymphatic endothelium and describes current understanding of the importance of S1P/S1PR signaling in regulation of barrier functions. Most studies thus far have been primarily focused on the role of the S1P/S1PR1 axis in vasculature and have been summarized in several excellent reviews, and thus, we will only discuss new perspectives on the molecular mechanisms of action of S1P and its receptors. Much less is known about the responses of the lymphatic endothelium to S1P and the functions of S1PRs in lymph endothelial cells, and this is the major focus of this review. We also discuss current knowledge related to signaling pathways and factors regulated by the S1P/S1PR axis that control lymphatic endothelial cell junctional integrity. Gaps and limitations in current knowledge are highlighted together with the need to further understand the role of S1P receptors in the lymphatic system.

Citing Articles

Regulatory role of S1P and its receptors in sepsis-induced liver injury.

Wang B, Wu X, Cheng J, Ye J, Zhu H, Liu X Front Immunol. 2025; 16:1489015.

PMID: 39935473 PMC: 11811114. DOI: 10.3389/fimmu.2025.1489015.


The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers.

Liu B, Zhou J, Jiang B, Tang B, Liu T, Lei P Front Immunol. 2024; 15:1511283.

PMID: 39650647 PMC: 11621088. DOI: 10.3389/fimmu.2024.1511283.


Engineering of Saccharomyces cerevisiae as a platform strain for microbial production of sphingosine-1-phosphate.

Jang I, Lee S, Bahn Y, Baek S, Yu B Microb Cell Fact. 2024; 23(1):310.

PMID: 39550572 PMC: 11569612. DOI: 10.1186/s12934-024-02579-8.


Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management.

Kitsou K, Kokkotis G, Rivera-Nieves J, Bamias G Drugs. 2024; 84(10):1179-1197.

PMID: 39322927 DOI: 10.1007/s40265-024-02094-5.


The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function.

Sikdar S, Mitra D, Das O, Bhaumik M, Dutta S Front Pharmacol. 2024; 15:1407228.

PMID: 39224783 PMC: 11366638. DOI: 10.3389/fphar.2024.1407228.